1. Dressman J, Kramer J. Pharmaceutical dissolution testing. New York: Marcel Dekker; 2005. https://doi.org/10.1201/9780849359170.
2. Azarmi S, Roa W, Lobenberg R. Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharm. 2007;328(1):12–21. https://doi.org/10.1016/j.ijpharm.2006.10.001.
3. FDA guidance for industry, dissolution testing of immediate release solid oral dosage forms. 1997. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/dissolution-testing-immediate-release-solid-oral-dosage-forms.
4. FDA guidance for Industry, SUPAC-MR: modified release solid oral dosage forms scale-up and postapproval changes: chemistry, manufacturing, and controls; in vitro dissolution testing and in vivo bioequivalence documentation: guidance for industry. 1997. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/supac-mr-modified-release-solid-oral-dosage-forms-scale-and-postapproval-changes-chemistry.
5. FDA guidance for Industry, SUPAC-IR: immediate-release solid oral dosage forms: scale-up and post-approval changes: chemistry, manufacturing and controls, in vitro dissolution testing, and in vivo bioequivalence documentation. 1995. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/supac-ir-immediate-release-solid-oral-dosage-forms-scale-and-post-approval-changes-chemistry.